Procter & Gamble (NYSE:PG) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

Procter & Gamble (NYSE:PG) had its target price raised by investment analysts at JPMorgan Chase & Co. from $162.00 to $180.00 in a research note issued to investors on Friday, Benzinga reports. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective points to a potential upside of 11.72% from the company’s current price.

A number of other research firms have also recently commented on PG. Jefferies Financial Group increased their price target on Procter & Gamble from $177.00 to $179.00 and gave the company a “buy” rating in a research note on Friday, June 26th. Wells Fargo & Company boosted their target price on shares of Procter & Gamble from $164.00 to $180.00 and gave the stock an “overweight” rating in a research report on Friday. HSBC reaffirmed a “hold” rating and issued a $149.00 price target (down from $182.00) on shares of Procter & Gamble in a report on Thursday, July 30th. Bank of America lowered their price objective on shares of Procter & Gamble from $170.00 to $166.00 and set a “buy” rating for the company in a research note on Friday, July 10th. Finally, Morgan Stanley boosted their target price on shares of Procter & Gamble from $166.00 to $185.00 and gave the company an “overweight” rating in a research report on Friday. Fourteen equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Procter & Gamble currently has an average rating of “Moderate Buy” and a consensus price target of $167.00.

Procter & Gamble Stock Down 2.7%

NYSE:PG traded down $4.47 during midday trading on Friday, reaching $161.12. 3,374,824 shares of the stock traded hands, compared to its average volume of 9,732,704. The stock has a market capitalization of $374.24 billion, a PE ratio of 24.34, a price-to-earnings-growth ratio of 3.90 and a beta of 0.39. Procter & Gamble has a 12-month low of $137.62 and a 12-month high of $167.25. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.47 and a current ratio of 0.68. The business has a 50-day moving average of $148.08 and a two-hundred day moving average of $146.99.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.89 by $0.11. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The business had revenue of $23.28 billion for the quarter, compared to analyst estimates of $22.80 billion. During the same period in the previous year, the company earned $1.99 earnings per share. The business’s revenue for the quarter was up 4.0% on a year-over-year basis. On average, equities analysts forecast that Procter & Gamble will post 6.98 earnings per share for the current fiscal year.

Insider Activity at Procter & Gamble

In other news, insider Marc S. Pritchard sold 4,030 shares of the stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $143.79, for a total value of $579,473.70. Following the completion of the sale, the insider owned 187,001 shares in the company, valued at $26,888,873.79. This represents a 2.11% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Andre Schulten sold 3,914 shares of the stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $568,860.76. Following the completion of the sale, the chief financial officer owned 65,618 shares of the company’s stock, valued at approximately $9,536,920.12. The trade was a 5.63% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 15,135 shares of company stock worth $2,189,970 in the last ninety days. 0.23% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Gibbs Wealth Management increased its holdings in Procter & Gamble by 34.4% in the 3rd quarter. Gibbs Wealth Management now owns 8,040 shares of the company’s stock valued at $1,168,000 after acquiring an additional 2,060 shares during the last quarter. Garrett Wealth Advisory Group LLC raised its stake in Procter & Gamble by 1.1% in the 3rd quarter. Garrett Wealth Advisory Group LLC now owns 7,066 shares of the company’s stock worth $1,026,000 after acquiring an additional 75 shares during the last quarter. Tectonic Advisors LLC boosted its stake in shares of Procter & Gamble by 9.3% during the 3rd quarter. Tectonic Advisors LLC now owns 78,030 shares of the company’s stock worth $11,336,000 after acquiring an additional 6,661 shares in the last quarter. Winthrop Advisory Group LLC raised its stake in Procter & Gamble by 2.4% in the 3rd quarter. Winthrop Advisory Group LLC now owns 10,618 shares of the company’s stock valued at $1,543,000 after purchasing an additional 250 shares during the last quarter. Finally, Capital Investment Advisors LLC grew its holdings in Procter & Gamble by 3.8% in the 3rd quarter. Capital Investment Advisors LLC now owns 462,434 shares of the company’s stock valued at $67,182,000 after buying an additional 17,061 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.

Key Headlines Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Sales and earnings exceeded expectations. Fiscal first-quarter EPS was $2.00 versus the $1.89 consensus, while revenue rose 4% year over year to $23.28 billion, ahead of estimates. Procter & Gamble earnings beat as sales rise 4%
• Positive Sentiment: Underlying demand improved. Organic sales grew 4%, with volume contributing 2.4 percentage points. Strength in laundry, home-care products and favorable product mix helped offset pressure on consumers and supported operating leverage. Procter & Gamble: 3 Key Takeaways for Long-Term Investors
• Positive Sentiment: Analyst sentiment and the sales outlook improved. TD Cowen raised its price target from $150 to $166 while maintaining a Hold rating. P&G also lifted its fiscal 2027 all-in sales-growth outlook, partly reflecting the Thorne acquisition.
• Neutral Sentiment: Management remains focused on resilience and productivity. The company said consumer demand remains solid and expects productivity savings and mix benefits to aid profitability, but the full-year outlook leaves limited room for further upside. Procter & Gamble: Improving Operating Leverage
• Negative Sentiment: Commodity, energy and transportation costs are rising. P&G warned that higher input costs could create an approximately $1.4 billion annual headwind, pressuring margins and potentially offsetting sales gains. P&G flags bigger hit to annual profit
• Negative Sentiment: Guidance creates uncertainty. Fiscal 2027 revenue guidance of $86.0 billion-$87.7 billion is below the $88.8 billion consensus, while margins remain under pressure. After the recent surge toward a 52-week high, profit-taking and concerns about valuation may be weighing on PG.

About Procter & Gamble

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.